Table 1

Clinical characteristics and metabolic parameters (means ± SD) of women with pGDM and their insulin-resistant (pGDM-IR) and insulin-sensitive (pGDM-IS) subgroups compared with control subjects (CON)

pGDMpGDM-IRpGDM-ISCONP
N231498
Age (years)37 ± 537 ± 5.939 ± 335 ± 4NS*NSNS0.06§
Time after delivery (m)57 ± 1156 ± 1459 ± 645 ± 150.02*NSNSNS§
BMI (kg/m2)25.5 ± 3.626.5 ± 3.024.2 ± 4.125.0 ± 2.9NS*NSNSNS§
BFM (kg)24.5 ± 626.1 ± 5.122.2 ± 6.818.0 ± 3.3<0.03*NS<0.02NS§
Waist circumference (cm)85.5 ± 9.487.9 ± 7.382.2 ± 11.276.0 ± 8.20.03*NS0.02NS§
Triglycerides (mg/dL)85.2 ± 38.694.1 ± 42.471.3 ± 28.797.0 ± 37.5NS*NSNSNS§
HDL-cholesterol (mg/dL)55.6 ± 12.552.8 ± 13.359.9 ± 10.464.5 ± 10.1<0.05*NS0.02NS§
A1C (%)5.4 ± 0.45.3 ± 0.55.4 ± 0.35.2 ± 0.2NS*NSNSNS§
GGT (units/L)18 ± 720 ± 715 ± 623 ± 24NS*0.03NSNS§
Adiponectin (µg/mL)7.9 ± 2.57.3 ± 2.28.9 ± 2.79.1 ± 2.3NS*NSNSNS§
us-CRP (mg/dL)0.19 ± 1.670.20 ± 0.170.17 ± 0.180.25 ± 0.24NS*NSNSNS§
Physical activity score2.68 ± 0.512.58 ± 0.52.85 ± 0.532.75 ± 0.12NS*NSNSNS§
Resting energy expenditure (kcal/24 h)1541 ± 2551587 ± 2501449 ± 2701440 ± 215NS*NSNSNS§
  • IR was defined by means of OGIS <462.8 mL ⋅ min−1 ⋅ m−2.

  • GGT, gamma glutamyl transferase; us-CRP, ultra-sensitive C-reactive protein.

  • *pGDM vs. CON.

  • †pGDM-IS vs. pGDM-IR.

  • ‡pGDM-IR vs. CON.

  • §pGDM-IS vs. CON.